Remove Cannabinoids Remove Clinical Trials Remove Concentrates Remove Pharmaceutical
article thumbnail

Clinical Trial Explores CBD’s Influence on Cannabis Safety

Veriheal

Serial plasma concentrations of THC and CBD were also measured. On the other hand, they observed a dose-response connection between CBD dose and plasma CBD concentration, with no noticeable effect on plasma THC concentrations. Fluctuations in the severity of psychotic symptoms (e.g., Gaia Herbs Hemp, and Joy Organics.

article thumbnail

The Cannabis Cancer Connection

Project CBD

There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. 11,141,404, titled “Formulations And Methods For Treating Acute Cannabinoid Overdose.” ” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose.

article thumbnail

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S.

article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

With clinical research developing rapidly in Israel and with the use of innovative technology we hope to have this information in the near future. For now, we can use a variety of strains in the form of concentrated cannabis oil to hopefully get lucky and find the right one.

article thumbnail

‘The most meaningful cannabis reform in decades’: Experts weigh in on new DEA rules

The Cannigma

‘Junk’ cannabis ‘ill-suited for clinical trials’. The cannabis grown at the University of Mississippi “is junk, ill-suited for clinical trials, and genetically closer to hemp than the marijuana available from dispensaries and used by Americans nationwide,” according to the lawsuit. Shutterstock). A promise made years ago.

DEA 133
article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

With clinical research developing rapidly in Israel and with the use of innovative technology we hope to have this information in the near future. For now, we can use a variety of strains in the form of concentrated cannabis oil to hopefully get lucky and find the right one.